PubMed for id: 99571

Year	Number of Results
1988	2
1991	1
1992	5
1993	7
1994	4
1996	2
1997	3
1998	3
1999	4
2000	6
2001	4
2002	5
2003	5
2004	6
2005	4
2006	6
2007	3
2008	5
2009	4
2010	4
2011	6
2012	5
2013	1
2014	4
2015	2
2016	3
2017	3
2018	1
2019	4
2020	2
2021	1
2022	1
2023	3
2024	0

1

Altered fibrinogen γ-chain cross-linking in mutant fibrinogen-γ^Δ5 mice drives acute liver injury.

Poole LG, Schmitt LR, Schulte A, Groeneveld DJ, Cline HM, Sang Y, Hur WS, Wolberg AS, Flick MJ, Hansen KC, Luyendyk JP. Poole LG, et al. J Thromb Haemost. 2023 Aug;21(8):2175-2188. doi: 10.1016/j.jtha.2023.04.003. Epub 2023 Apr 14. J Thromb Haemost. 2023. PMID: 37062522

2

γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke.

van den Herik EG, Cheung EY, de Lau LM, den Hertog HM, Leebeek FW, Dippel DW, Koudstaal PJ, de Maat MP. van den Herik EG, et al. Thromb Haemost. 2011 Mar;105(3):430-4. doi: 10.1160/TH10-09-0569. Epub 2010 Dec 6. Thromb Haemost. 2011. PMID: 21136017

3

Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen.

Steinbrecher KA, Horowitz NA, Blevins EA, Barney KA, Shaw MA, Harmel-Laws E, Finkelman FD, Flick MJ, Pinkerton MD, Talmage KE, Kombrinck KW, Witte DP, Palumbo JS. Steinbrecher KA, et al. Cancer Res. 2010 Apr 1;70(7):2634-43. doi: 10.1158/0008-5472.CAN-09-3465. Epub 2010 Mar 16. Cancer Res. 2010. PMID: 20233870 Free PMC article.

4

Fibrinogen facilitates the anti-tumor effect of nonnative endostatin.

Tang H, Fu Y, Lei Q, Han Q, Ploplis VA, Castellino FJ, Li L, Luo Y. Tang H, et al. Biochem Biophys Res Commun. 2009 Mar 6;380(2):249-53. doi: 10.1016/j.bbrc.2009.01.045. Epub 2009 Jan 22. Biochem Biophys Res Commun. 2009. PMID: 19167351 Free PMC article.

5

The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.

Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K. Adams RA, et al. J Exp Med. 2007 Mar 19;204(3):571-82. doi: 10.1084/jem.20061931. Epub 2007 Mar 5. J Exp Med. 2007. PMID: 17339406 Free PMC article.

6

Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice.

Cruz-Topete D, Iwaki T, Ploplis VA, Castellino FJ. Cruz-Topete D, et al. J Pathol. 2006 Nov;210(3):325-33. doi: 10.1002/path.2060. J Pathol. 2006. PMID: 16981239

7

Neonatal bleeding and decreased plasma fibrinogen levels in mice modeled after the dysfibrinogen Vlissingen/Frankfurt IV.

Hogan KA, Merenbloom BK, Kim HS, Lord ST. Hogan KA, et al. J Thromb Haemost. 2004 Aug;2(8):1484-7. doi: 10.1111/j.1538-7836.2004.00841.x. J Thromb Haemost. 2004. PMID: 15304068 Free article. No abstract available.

8

Pathophysiologic roles of the fibrinogen gamma chain.

Farrell DH. Farrell DH. Curr Opin Hematol. 2004 May;11(3):151-5. doi: 10.1097/01.moh.0000131440.02397.a4. Curr Opin Hematol. 2004. PMID: 15257013 Review.

9

Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo.

Flick MJ, Du X, Witte DP, Jirousková M, Soloviev DA, Busuttil SJ, Plow EF, Degen JL. Flick MJ, et al. J Clin Invest. 2004 Jun;113(11):1596-606. doi: 10.1172/JCI20741. J Clin Invest. 2004. PMID: 15173886 Free PMC article.

10

Synthesis of a mouse model of the dysfibrinogen Vlissingen/Frankfurt IV.

Hogan KA, Maeda N, Kluckman KD, Lord ST. Hogan KA, et al. Ann N Y Acad Sci. 2001;936:117-21. doi: 10.1111/j.1749-6632.2001.tb03498.x. Ann N Y Acad Sci. 2001. PMID: 11460467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

112 results

Results by year